FDA Investigator Lisa Mathew
Lisa Mathew has conducted inspections on 94 sites in 1 countries as of 16 Aug 2010. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
94
Last Inspection Date:
16 Aug 2010
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lisa Mathew:
Alberto A Viciedo,
Alia Legaux,
Alice S Tsao,
Allen Lou,
Althea A Williams,
Amber D Brodas,
Amy Constantine,
Amy Kim,
Amy L Singer,
Amy Wyan Mai,
Ana S Cabrera,
Andrew F Cohen,
Angela Jourdain,
Ann B Okon,
Anthony M Criscuolo, Jr,
Arduino Frankovic,
Arthur S Williams, Jr,
Ashley Polizzotto,
Ayorinde O Babalola,
Barbara J Maulfair,
Barbara L Williams,
Barbara Paul,
Betty M Ng Lee,
Bijoy Panicker,
Brandi L Garbutt,
Bruce G Cooper,
Burnell M Henry,
Carley R Anderson,
Carrie E Jolly,
Cary Greene,
Charles J Chacko,
Christian Parra,
Christina N Maurino,
Christopher J Adams,
Dana A Razzano,
Dave M Deroche,
David A Laplante,
David H Smith,
David J Leray,
David M Mcnew,
Dawn L Wydner,
Deborah B Nixon,
Denise M Visco, Investigator,
Diane B Radice,
Dipesh K Shah,
Donald G Gordon,
Donald J Ullstrom,
Douglas C Kovacs,
Douglas G Ng,
Dr. Barbara D Paul, PhD,
Dr. Gang Wang, PhD,
Edward O'shaughnessy,
Ellen M Landis,
Emilio Z Azukwu,
Emily A Walters,
Eric Rothschild,
Erin D Mccaffery,
Esteban Beltran,
Eufemia G Gonzalez,
Evelyn Taha,
Frank J Marciniak,
Frank Verni,
Gayle J Gehrman,
Gene D Arcy,
Geoffrey B Ward,
George C Amedro,
George M Ibrahim,
Gianine E Tompkins,
Gloria E Parra,
Gobiga Vanniyasingam,
Gregson A Joseph,
Haydee B Romero,
Helen B Ricalde,
Iram R Hassan, PhD,
Irina Gaberman,
Jack J Lohne,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James A Liubicich,
Jane C Chen,
Jason Kwong,
Jean M Kelahan,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Jessica M Monteiro,
John E Aghadia,
Jonathan Ho,
Jonee J Mearns,
Jose M Cayuela,
Joseph Maselli,
Joshua D Lopez,
Joy P Matthias,
Juanita P Versace,
Judy Keihl,
Juliana Falla,
Karen E D'orazio,
Kathleen B Swat,
Kathryn A Nagy,
Kelli F Dobilas,
Kellie Leveille,
Kelly I Anderson,
Kelly L Anderson,
Kenneth G Klobus,
Kerun Hardeo,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kinh Q Mac,
Kristy A Zielny,
Kwong P Lee,
Kyle J Spencer,
L Gnnmassimia Massimilla, PharmD,
Laura M Howard,
Laura Schankweiler,
Lawrence H Patrick,
LCDR Chad N Thompson,
Leena Thomas,
Li Li,
Lisa Harlan,
Loretta Nemchik,
LT Colin E Tack, BSE,
LTJG Matthew R Palo,
Marcelo O Mangalindan, Jr,
Margaret E Sarles,
Margaret M Sands,
Mary M Finn,
Melissa A Henaghan,
Melissa B Libby,
Melissa T Roy,
Mercy O Quagraine,
Meredith P Soehl, Investigator,
Michael G Sinkevich,
Michael R Dominick,
Michael Serrano,
Mohammad Heidaran, PhD,
Morgan J Matthews,
Morris Paul,
Mouhamed H Halwani,
Naakesh N Gomanie,
Nancy A Saxenian Emmons,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas C Mendiola,
Nicholas E Squillante,
Nina Yang,
Paul E Stein,
Paul M Gelfand,
Paul Mouris,
Perez,
Perry T Nichols,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Peter R Lenahan,
Ramni J Tandon,
Randi Lynn Bodoh,
Randi Lynn Spencer,
Raymond M Lam,
Regina T Brown,
Remache,
Richard D Manney,
Robert C Steyert,
Robert G Ruff,
Robert J Veitch,
Ronald Ifraimov,
Russ E Davis,
Russell J Glapion,
Sandra Kershaw,
Sarah A Meehan,
Sarah Forney,
Sasha M Latonis,
Satheesh Thomas,
Schultz,
Sherona A Ryder,
Sherri J Liu,
Shirley S Wen,
Shreya Shah,
Sinai I Davis,
Sonia E Ortiz,
Stanley Noneze,
Susan T Hadman,
Tammy S Notto,
Tania E Vizcaino,
Tara K Carmody,
Tara K Normandin,
Thomas P Hansen,
Tracy M Portelli,
Vaishali J Patel,
Valerie A Potopsingh,
Valerie C Reed,
Valerie Jgrecek Trinh,
Vincent T Duncan,
Wayne J Meyer,
Wendy M Stone,
William P Chilton,
William R Chang,
Xiaokuang Lai, PhD,
Yong Hu,
Yuyan Liang,
Yvesna C Blaise,
Yvonne M Santiago
Lisa Mathew's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2004 | FDA 483 | Sandra C. Belmont, M.D. - Form 483, 2004-02-10 |
| February, 2004 | EIR | Sandra C. Belmont, M.D. - EIR, 2004-02-10 |
| January, 2010 | EIR | Celularity, Inc. dba LifebankUSA - EIR, 2010-01-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more